Cite
HARVARD Citation
Iwata, H. et al. (n.d.). 37OSubgroup analysis of IMpassion130: Atezolizumab + nab-paclitaxel (nab-P) in patients (pts) with advanced triple-negative breast cancer (TNBC) in Asian countries. Annals of oncology. p. . [Online].